A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Clinical trial NCT00060502 · COMPLETED

Trial details

NCT number: NCT00060502
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cachexia Pancreatic Neoplasms

Start date: 2003-04-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.